CD276 and cancer: Additionally, the KEGG enrichment analysis indicated that “Proteoglycans in cancer”, “Focal adhesion”, “ECM-receptor interaction”, and the “PI3K-Akt signaling pathway” might be involved in CD276-mediated TME reconstruction (Figure 5E).